Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?
Saved in:
| Title: | Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease? |
|---|---|
| Authors: | Bellingrath JS; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., McClements ME; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Fischer MD; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom., MacLaren RE; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom. |
| Source: | Frontiers in molecular neuroscience [Front Mol Neurosci] 2023 May 24; Vol. 16, pp. 1092913. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477914 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5099 (Print) Linking ISSN: 16625099 NLM ISO Abbreviation: Front Mol Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1662-5099 |
|---|---|
| DOI: | 10.3389/fnmol.2023.1092913 |
